Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Two studies of blood pressure (BP) elevation associated with pregnancy and the oral contraceptive
ISRCTN ISRCTN00582888
ClinicalTrials.gov identifier
Public title Two studies of blood pressure (BP) elevation associated with pregnancy and the oral contraceptive
Scientific title
Acronym N/A
Serial number at source N0241048443
Study hypothesis 1. Do combined oral contraceptives (COC) exert a differential effect on the blood pressures (BP) of women with and without a past history of BP elevation in pregnancy?
2. Do oral progestrogen only contraceptives produce a significant elevation of BP in women who have had COC induced hypertension?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular: Hypertension
Participants - inclusion criteria Study 1 - 25 women who have developed significant BP elevation and 25 who have never suffered raised BP during pregnancy.
Study 2 - 50 women with a history of raised BP in association with taking oral contraceptive.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/08/2000
Anticipated end date 31/12/2005
Status of trial Completed
Patient information material
Target number of participants 75
Interventions Study 1 (controlled trial):
25 women who have developed significant BP elevation during pregnancy and 25 who have never suffered raised BP during pregnancy will receive combined oral contraceptives.

Study 2 (randomised controlled trial):
50 women with a history of raised BP in association with taking oral contraceptives will be randomised to receive a progestrogen-only contraceptive versus a placebo.
Primary outcome measure(s) First in a series of collaborative studies between CVSU, Obs & Gynae and Vascular Biology (Clin Pharm).
Secondary outcome measure(s) Not provided at time of registration
Sources of funding St Mary's NHS Trust (UK)
Trial website
Publications
Contact name Prof  Neil  Poulter
  Address Clinical Pharmacology
Cardiovascular Studies Unit
St Mary's Hospital
Praed Street
  City/town London
  Zip/Postcode W2 1NY
  Country United Kingdom
  Tel +44 (0)20 7594 3445
  Email n.poulter@ic.ac.uk
Sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 12/09/2003
Last edited 22/04/2008
Date ISRCTN assigned 12/09/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central